[Elsevier] LANCET - Efficacy and safety of oral orforglipron in Japanese participants with obesity disease (ATTAIN-J): a double-blind, randomised, placebo-controlled, parallel-group, phase 3 trial |
|
This post will be closed automatically in 2026-11-06 02:18
Reward40points
|
post
reply
points
8485
10
Consumer purchase intention during brand crisis: A study on intangible cultural heritage brands in the context of e-commerce live streaming
50
Microplastic emission characteristics of stormwater runoff in an urban area: Intra-event variability and influencing factor
10
Machine learning approach for longitudinal face recognition of children
10
Screening for autoimmune atrophic gastritis by serum gastrin measurement in subjects with type 1 diabetes
